MedPath
FDA Approval

Betamethasone Valerate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Betamethasone(1.2 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RPK Pharmaceuticals, Inc.

RPK Pharmaceuticals, Inc.

147096275

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betamethasone Valerate

Product Details

NDC Product Code
53002-8450
Application Number
ANDA070069
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
December 17, 2020
Code: 9IFA5XM7R2Class: ACTIBQuantity: 1.2 mg in 1 g
PETROLATUMInactive
Code: 4T6H12BN9UClass: IACT
LANOLIN ALCOHOLSInactive
Code: 884C3FA9HEClass: IACT
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath